NCT07448454

Brief Summary

This work aims to clarify the diagnostic ability of vessel wall MRI to differentiate between intracranial atherosclerotic disease and vasculitis as causes of ischemic stroke, thereby guiding appropriate treatment and improving patient outcomes.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
10mo left

Started Mar 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress21%
Mar 2026Apr 2027

First Submitted

Initial submission to the registry

February 20, 2026

Completed
9 days until next milestone

Study Start

First participant enrolled

March 1, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 4, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2027

Last Updated

March 4, 2026

Status Verified

February 1, 2026

Enrollment Period

1 year

First QC Date

February 20, 2026

Last Update Submit

February 28, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Role of vessel wall MRI in differentiation between intracranial atherosclerotic disease and vasculitis as causes of ischemic stroke by detection of eccentric or circumferential arterial wall thickening and pattern of postcontrast enhancement.

    Vessel wall MR sequences including T1 pre and post contrast in order to differentiate between intracranial atherosclerotic plaque and vasculitis and to assess atherosclerotic plaque activity by detection of eccentric or circumferential arterial wall thickening and pattern of postcontrast enhancement. According to previous studies, if there is enhancing eccenteric arterial wall thickening, it considered active athrosclerotic plaque, if there is non enhancing eccenteric aretrial wall thickening, it considered inactive atherosclerotic plaque. If there is enhancing circumferential arterial wall thickening, it considered vasculitis

    Baseline

Study Arms (1)

No Arms have been specified for this study.

OTHER
Device: MRI

Interventions

MRIDEVICE

Vessel wall MRI in differentiation between intracranial atherosclerotic disease and vasculitis as causes of ischemic stroke

No Arms have been specified for this study.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with ischemic stroke within 2 weeks from onset detected by magnetic resonance imaging (MRI) and have intracranial artery stenosis seen in magnetic resonance angiography (MRA).

You may not qualify if:

  • Contraindications for MRI such as claustrophobia, heart pacemaker and ferromagnetic implants.
  • Contraindications for contrast as patients with renal impairment.
  • Patients in which the misaligned images or distortions due to motion artifacts made the interpretation of the MRI unreliable.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (9)

  • Li F, Wang Y, Hu T, Wu Y. Application and interpretation of vessel wall magnetic resonance imaging for intracranial atherosclerosis: a narrative review. Ann Transl Med. 2022 Jun;10(12):714. doi: 10.21037/atm-22-2364.

    PMID: 35845481BACKGROUND
  • D'Aniello S, Rustici A, Gramegna LL, Godi C, Piccolo L, Gentile M, Zini A, Carrozzi A, Lodi R, Tonon C, Dall'Olio M, Simonetti L, Chieffo R, Anzalone N, Cirillo L. The Contribution of Vessel Wall Magnetic Resonance Imaging to the Diagnosis of Primary and Secondary Central Nervous System Vasculitis. Diagnostics (Basel). 2024 Apr 29;14(9):927. doi: 10.3390/diagnostics14090927.

    PMID: 38732340BACKGROUND
  • Hu T, Ling R, Zhu Y. Advancements in imaging of intracranial atherosclerotic disease: beyond the arterial lumen to the vessel wall. Rev Neurosci. 2024 Nov 19;36(3):229-241. doi: 10.1515/revneuro-2024-0076. Print 2025 Apr 28.

    PMID: 39565965BACKGROUND
  • Chaganti J, Woodford H, Tomlinson S, Dunkerton S, Brew B. Black blood imaging of intracranial vessel walls. Pract Neurol. 2020 Dec 29:practneurol-2020-002806. doi: 10.1136/practneurol-2020-002806. Online ahead of print.

    PMID: 33376151BACKGROUND
  • Mazzacane F, Mazzoleni V, Scola E, Mancini S, Lombardo I, Busto G, Rognone E, Pichiecchio A, Padovani A, Morotti A, Fainardi E. Vessel Wall Magnetic Resonance Imaging in Cerebrovascular Diseases. Diagnostics (Basel). 2022 Jan 20;12(2):258. doi: 10.3390/diagnostics12020258.

    PMID: 35204348BACKGROUND
  • Alzein MM, Patel A, Abdalla RN, Cantrell DR, Shaibani A, Ansari SA. MR Vessel Wall Imaging for Atherosclerosis and Vasculitis. Neuroimaging Clin N Am. 2024 May;34(2):251-260. doi: 10.1016/j.nic.2024.02.001.

    PMID: 38604709BACKGROUND
  • Edjlali M, Qiao Y, Boulouis G, Menjot N, Saba L, Wasserman BA, Romero JM. Vessel wall MR imaging for the detection of intracranial inflammatory vasculopathies. Cardiovasc Diagn Ther. 2020 Aug;10(4):1108-1119. doi: 10.21037/cdt-20-324.

    PMID: 32968663BACKGROUND
  • Tritanon O, Mataeng S, Apirakkan M, Panyaping T. Utility of high-resolution magnetic resonance vessel wall imaging in differentiating between atherosclerotic plaques, vasculitis, and arterial dissection. Neuroradiology. 2023 Mar;65(3):441-451. doi: 10.1007/s00234-022-03093-7. Epub 2022 Dec 2.

    PMID: 36456894BACKGROUND
  • Kang DW, Kim DY, Kim J, Baik SH, Jung C, Singh N, Song JW, Bae HJ, Kim BJ. Emerging Concept of Intracranial Arterial Diseases: The Role of High Resolution Vessel Wall MRI. J Stroke. 2024 Jan;26(1):26-40. doi: 10.5853/jos.2023.02481. Epub 2024 Jan 30.

    PMID: 38326705BACKGROUND

MeSH Terms

Conditions

Vasculitis

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Central Study Contacts

Mahmoud Abdelbaset Mahmoud, MSC

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Invistigator

Study Record Dates

First Submitted

February 20, 2026

First Posted

March 4, 2026

Study Start

March 1, 2026

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

April 1, 2027

Last Updated

March 4, 2026

Record last verified: 2026-02